Find what matters to you

Attending PAINWeek this year was especially meaningful because pain research has been a major part of my career. Over the past 12 years, I have worked on more than 50 […]

Staying cohesive through long and complex Parkinson’s disease trials Parkinson’s disease trials, like most clinical trials, are rarely a straight path from start to finish. Protocols evolve, real-world conditions change, […]

Six challenges in acute pain trials and one differentiator—coordinated execution We’ve all been there before. Your acute pain trial strategy is sound, the protocol looks solid, and everything progresses as […]

Acute pain trials start with assumptions. How you execute—when reality sets in—determines the outcome. When you’re designing an acute pain clinical trial, it’s perfectly normal to have some early assumptions […]

Early in clinical development, it’s easy to focus on what’s directly in front of you. After all, your goal is to hit milestones, generate strong data, and keep the program […]

Parkinson’s disease trials are not only complex studies, but they are long, personal commitments for every patient, caregiver, and investigator involved. That raises the question: Is your study truly structured […]

How confident are you that your acute pain study will behave the way it’s designed to? In planning sessions, most protocols look neat and predictable. But the moment your study […]

Early clinical decisions shape regulatory risk and the path to approval   Assumptions about study design and real-world execution don’t stay contained to a single milestone. Over time, they influence […]

Four scientific principles. One unifying concept. The Cohesion Effect experience. SCOPE Summit is a place where innovation thrives. Thousands of attendees and hundreds of exhibitors from around the world, all […]

When Tonix came to us, the stakes were high, and the timelines were tight. Their goal? To submit a New Drug Application (NDA) for TONMYA™ and, for the first time […]